Clinical Trial

Clinical Characteristics and Prognosis of Simultaneous Versus Delayed Resection for Synchronous Colorectal Liver Metastasis: A Nationwide Multicenter Study Utilizing Propensity Score Matching Analysis

Completed
View on ClinicalTrials.gov →
Summary
Colorectal cancer (CRC) often metastasizes to the liver, with synchronous metastases observed in 20% of cases. Surgical resection is the primary treatment, but the impact of simultaneous and staged resections on clinical outcomes remains unclear. This study employs propensity score matching (PSM) in a nationwide survey to compare clinical characteristics, complications, and survival, providing valuable insights for optimizing the management of colorectal liver metastases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-16.
Trial Details
NCT Number NCT07082335
Lead Sponsor Shanghai 10th People's Hospital
Collaborators: RenJi Hospital
Conditions Colorectal Cancer (CRC)
Enrollment 679 participants
Start Date 2019-01-01
Primary Completion 2021-01-01 (estimated)
Study Completion 2024-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22